Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, secures €8.5million in seed funding. A syndicate of experienced life science invest… Read More
Planegg/Martinsried (IRW-Press/15.05.2024) – Die Medigene AG (Medigene oder das „Unternehmen“, FWB: MDG1, Prime Standard) ein immunonkologisches Plattformunternehmen, das… Read More
Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a… Read More
Planegg/Martinsried (IRW-Press / 25.04.2024)
Die Medigene AG (Medigene oder das „Unternehmen“, FWB: MDG1, Prime Standard) ein immunonkologisches Plattformunternehmen, das sich… Read More
Richmond, United States, 2024-Apr-12 — /EPR Network/ — The TCR Therapy Market, valued at USD 330 Million, is projected to reach USD 3,145.3 Million by 2030. [read full press… Read More
[Research Report] The antibody discovery market size is projected to surge from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030; the market is estimated to grow at a CAGR of 6.7% d… Read More
Immune cell engineering is an emerging field that holds promise for developing next-generation cell therapies. By reprogramming a patient’s own immune cells, researchers are working to… Read More
Planegg/Martinsried (19.02.2024)
Die Medigene AG (Medigene oder das „Unternehmen“, FWB: MDG1, Prime Standard) ein immunonkologisches Plattformunternehmen, das sich auf die Erfo… Read More
Planegg/Martinsried (12.02.2024)
– Magenkrebs, Eierstockkrebs, myxoides/rundzelliges Liposarkom und synoviales Sarkom wurden als erste klinische Indikationen für das Leitprogram… Read More
Electronic Cigarettes / Vapes: A-Z Glossary of Terms
Below is a collection of terms you might hear in the vaping scene. We will keep this updated to help you understand all of the “ja… Read More
A detailed analysis of the Global T-Cell Therapy Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, comp… Read More
Cancer immunotherapy has gained attention in recent years due to its potential in the treatment of cancer. T-cell therapy and CAR-T cell therapy are the two major forms of immunotherapies us… Read More
Presented updated data from Phase 1 clinical trial of CT-0508 at CAR-TCR Summit, further supporting CAR-M safety, feasibility and mechanism of action
Selected clinical candidate for CT-111… Read More
Sen. Bernie Sanders is once again keeping drug makers in check, suggesting that people living with cancer are being preyed on by greedy interests.
On Monday, Sanders demanded a Department of… Read More
Different Types Of T Cells And Their Functions – T cell therapy is a potential treatment for cancer that uses the T cells themselves as “living medicine”. T cells are cells… Read More
[Research Report] The T cell therapy market size was valued at US$ 2,754.0 million in 2022 and is expected to reach US$ 9,035.01 million by 2030. It is estimated to register a CAGR of 1… Read More
(Albany, United States) As per DelveInsight’s assessment, globally, the TCR Therapy pipeline constitutes 25+ key companies continuously working towards developing 25+ TCR Therapy trea… Read More
Osteosarcoma (OS) is a highly malignant stromal tumor composed of mesenchymal cells that produce osteoid and immature bone. The peak of incidence is in the second decade after birth. Althoug… Read More
First marketed engineered T-cell therapy for a solid tumor; BLA for afami-cel on track to complete submission in mid-2023Compelling clinical data with late-stage programs targeting MAGE-A4 a… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, CAR-T pipeline constitutes key companies continuously working towards developing CAR-T treatment therap… Read More
Planegg/Martinsried (04.04.2023) – Die Medigene AG (Medigene, FWB: MDG1, Prime Standard) ist ein Immunonkologie-Unternehmen, das sich auf die Erforschung und Entwicklung von T-Zell-Im… Read More
Mechanisms of Immune Escape in Tumors
Although the human immune system uses powerful immune cells and various immune measures, some immunogenic tumors evade clearance after initially bein… Read More
The Nutrigenomics market is expected to deliver robust growth over the forecast period, registering an impressive CAGR of 13%. The anticipated market growth is accredited to the significant… Read More
In an exclusive interview with cryptonews.com, Jacobc.eth, Founder of Hyperplay & Founding Contributor at Mantle, talks about creating decentralized trust via cryptoeconomic security… Read More
Introduction
Acute leukemias are a group of aggressive blood cancers that affect the white blood cells, which are responsible for fighting infections and diseases in the body. There are two… Read More
Planegg/Martinsried (11.04.2023) – Die Medigene AG (Medigene, FWB: MDG1, Prime Standard), ein immunonkologisches Plattformunternehmen, das sich auf die Erforschung und Entwicklung von… Read More
Research Nester released a report titled “Gene Modifying Immunotherapy for Blood Cancer Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers de… Read More
Introduction
The genomics market is a rapidly growing industry that is revolutionizing the healthcare industry. The market is driven by advances in genomics technologies, increasing utili… Read More
Car-T cells are a type of immune cell that are created by manipulating the DNA of a patient’s own T cells. This is done by introducing new genes that encode for proteins that can reco… Read More
TIGIT is considered to be one of the most promising and potential targets, and a variety of evidence supports that TIGIT plays a key role in limiting the adaptive and innate immunity of tumo… Read More
Singapore-based SCG Cell Therapy Pte Ltd (“SCG”) announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an… Read More
Philadelphia, Pennsylvania and Oxfordshire, United Kingdom--(Newsfile Corp. - October 27, 2022) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, will… Read More
T-cell transfer therapy is a class of immunotherapy used to treat various cancers.
T-cell transfer therapy consists of two main subclasses: tumor-infiltrating lymphocytes (TIL) therapy an… Read More
- 44% Objective Response Rate (ORR) with a single dose of ADP-A2M4CD8 in 25 heavily pre-treated patients with late-stage ovarian, urothelial, and head & neck cancers -- Further clinical… Read More
Research Nester released a report titled “Gene Modifying Immunotherapy for Blood Cancer Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers de… Read More
Dr. Jason Bock is a biopharma industry veteran who helped build the Biologics Development team that was formerly part of the Therapeutics Discovery division at the University of Texas MD And… Read More
The Asia Pacific cell therapy market size is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 1… Read More